Zusammenfassung
Epidemiologische Studien ergeben eine Prävalenz für den Morbus Adamantiades-Behçet (MAB) in einer Spanne von 0,12–420 auf 100.000 Einwohner mit den höchsten Raten in der Türkei und den niedrigsten in den USA. Es existieren kaum ophthalmologische Daten in Deutschland, da die meisten epidemiologischen Studien auf dermatologischen oder rheumatologischen Daten beruhen. Aufgrund der internationalen Bevölkerungsstruktur bot sich Berlin für eine ophthalmologische epidemiologische Untersuchung an. Wir haben die wichtigsten uns vorliegenden epidemiologischen Daten von 140 Patienten (63 w, 77 m) mit einem durchschnittlichen Follow-up von 6,4 Jahren (0,5 bis 22 Jahre), die wir in den letzten Jahren publiziert haben, zusammengefasst. Das mittlere Alter zum Zeitpunkt der ersten Manifestationen betrug 23 Jahre. Das Vollbild der Erkrankung bot sich im Mittel mit 32 Jahren. Das durchschnittliche Alter bei Augenbeteiligung betrug 30 Jahre. Insgesamt trat eine Augenbeteiligung bei 56% der Betroffenen auf, bei 8,6% als Erstmanifestation und bei 19,3% als Zweitmanifestation. Die berechnete Prävalenz für Berlin betrug 1,77/100.000 Einwohner.
Abstract
Epidemiological studies demonstrate a prevalence of Adamantiades-Behçets disease (MAB) in the range of 0.12–420 per 100,000 inhabitants with the highest rates in Istanbul, Turkey and the lowest rates in the USA. Ophthalmological data on the prevalence of ocular involvement are limited for MAB in Germany because most epidemiological studies are based on rheumatological or dermatological data. Berlin is the city with the highest number of non-native German inhabitants and its multiethnic character renders it uniquely appropriate for epidemiological studies on MAB. This article summarizes the most important epidemiological data of 140 patients (63 female and 77 male) with a mean follow-up of 6.4 years (range 0.5–22 years) which we have recently published. The mean age was 23 years at the first manifestation and 32 years when the fully developed disease was recorded. The mean age at onset of ocular involvement was 30 years, 56% of patients developed ocular involvement, which was the first manifestation in 8.6% and the second manifestation in 19.3%. More than half the patients developed ocular involvement. The calculated prevalence of ocular involvement in MAB is 1.77/100,000 inhabitants for the population of Berlin.
Literatur
Altenburg A, Papoutsis N, Orawa H et al (2006) Epidemiology and clinical manifestations of Adamantiades-Behcet disease in Germany – current pathogenetic concepts and therapeutic possibilities. J Dtsch Dermatol Ges 4:49–64; quiz 65–66
Ambresin A, Tran T, Spertini F, Herbort C (2002) Behcet’s disease in Western Switzerland: epidemiology and analysis of ocular involvement. Ocul Immunol Inflamm 10:53–63
Ando K, Fujino Y, Hijikata K et al (1999) Epidemiological features and visual prognosis of Behcet’s disease. Jpn J Ophthalmol 43:312–317
Azizlerli G, Kose AA, Sarica R et al (2003) Prevalence of Behcet’s disease in Istanbul, Turkey. Int J Dermatol 42:803–806
Benezra D, Cohen E (1986) Treatment and visual prognosis in Behcet’s disease. Br J Ophthalmol 70:589–592
Chung YM, Yeh TS, Sheu MM et al (1990) Behcet’s disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments. J Formos Med Assoc 89:413–417
International Study Group for Behcet’s Disease (o J) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080
Elgin U, Berker N, Batman A (2004) Incidence of secondary glaucoma in behcet disease. J Glaucoma 13:441–444
Escudier M, Bagan J, Scully C (2006) Number VII Behcet’s disease (Adamantiades syndrome). Oral Dis 12:78–84
Gurler A, Boyvat A, Tursen U (1997) Clinical manifestations of Behcet’s disease: an analysis of 2147 patients. Yonsei Med J 38:423–427
Hamdan A, Mansour W, Uthman I et al (2006) Behcet’s disease in Lebanon: clinical profile, severity and two-decade comparison. Clin Rheumatol 25:364–367
Kötter I, Vonthein R, Muller CA et al (2004) Behcet’s disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol 31:133–139
Krause L, Köhler AK, Altenburg A et al (2009) Ocular involvement is associated with HLA-B51 in Adamantiades-Behçet’s disease. Eye (Lond) 23(5):1182–1186
Krause L, Köhler AK, Altenburg A et al (2009) Ocular involvement in Adamantiades-Behçet’s disease in Berlin, Germany. Graefes Arch Clin Exp Ophthalmol 247(5):661–666
Krause L (2005) Adamantiades-Behcet’s disease. Ophthalmologe 102:329–334
Krist D, Schonherr U, Wenkel H (2000) Adamantiadis-Behcet syndrome: fluorescein angiography and choroid ischemia. Klin Monatsbl Augenheilkd 216:45–50
Mishima S, Masuda K, Izawa Y et al (1979) The eighth Frederick H. Verhoeff Lecture. Presented by Saiichi Mishima, MD Behcet’s disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc 77:225–279
Muhaya M, Lightman S, Ikeda E et al (2000) Behcet’s disease in Japan and in Great Britain: a comparative study. Ocul Immunol Inflamm 8:141–148
Ozdal PC, Ortac S, Taskintuna I, Firat E (2002) Posterior segment involvement in ocular Behcet’s disease. Eur J Ophthalmol 12:424–431
Papoutsis NG, Abdel-Naser MB, Altenburg A et al (2006) Prevalence of Adamantiades-Behçet’s disease in Germany and the municipality of Berlin: results of a nationwide survey. Clin Exp Rheumatol 24(Suppl 42):125
Saylan T, Ozarmagan G, Azizlerli G et al (1986) Behcet disease in Turkey. Z Hautkr 61:1120–1122
Shahram F, Davatchi F, Nadji A et al (2003) Recent epidemiological data on Behcet’s disease in Iran. The 2001 survey. Adv Exp Med Biol 528:31–36
Tanaka C, Matsuda T, Hayashi E et al (2003) Clinical manifestations and course of 200 Japanese patients with Behcet’s disease. Adv Exp Med Biol 528:77–79
Torres RM, Yanez B, Herreras JM, Calonge M (2004) Ocular Behcet disease. Retrospective study. Arch Soc Esp Oftalmol 79:599–603
Tugal-Tutkun I, Onal S, Altan-Yaycioglu R et al (2004) Uveitis in Behcet disease: an analysis of 880 patients. Am J Ophthalmol 138:373–380
Yoshida A, Kawashima H, Motoyama Y et al (2004) Comparison of patients with Behcet’s disease in the 1980s and 1990s. Ophthalmology 111:810–815
Zierhut M, Saal J, Pleyer U et al (1995) Behcet’s disease: epidemiology and eye manifestations in German and Mediterranean patients. Ger J Ophthalmol 4:246–251
Zouboulis CC, Turnbull JR, Martus P (2003) Univariate and multivariate analyses comparing demographic, genetic, clinical, and serological risk factors for severe Adamantiades-Behçet’s disease. In: Zouboulis CC (Hrsg) Adamantiades-Behçet’s disease. Kluwer/Plenum, London, S 123–126
Zouboulis CC (1999) Epidemiology of Adamantiades-Behcet’s disease. Ann Med Interne (Paris) 150:488–498
Zouboulis CC, May T (2003) Pathogenesis of Adamantiades-Behcet’s disease. Med Microbiol Immunol 192:149–155
Interessenkonflikt
Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kneifel, C., Köhler, AK., Altenburg, A. et al. Epidemiologie der Augenbeteiligung beim Morbus Adamantiades-Behçet. Ophthalmologe 109, 542–547 (2012). https://doi.org/10.1007/s00347-011-2503-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-011-2503-x